Completed NA INTERVENTIONAL 2-arm NCT04228523

Therapeutic Education in Parkinson's Disease: What Impact on Drug Representations of Patients? (ETPARK-REMED) (ETPARK-REMED)

Therapeutic Education in Parkinson's Disease: What Impact on Drug Representations of Patients?

Sponsor: France Parkinson Association

Interventions Speaking Therapy Therapeutic education workshop

Updated 8 times since 2020 Last updated: Nov 21, 2025 Started: Feb 24, 2020 Primary completion: Jan 1, 2021 Completion: Jan 1, 2021

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT04228523, this NA trial focuses on Parkinson Disease and remains completed. Sponsored by France Parkinson Association, it has been updated 8 times since 2020, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

8 versions recorded

Dec 2025 — Present [monthly]

Completed NA
Sep 2024 — Dec 2025 [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Sep 2023 — Jul 2024 [monthly]

Completed NA
Feb 2023 — Sep 2023 [monthly]

Completed NA

Status: Unknown Status → Completed

▶ Show 3 earlier versions

Jan 2022 — Feb 2023 [monthly]

Unknown Status NA

Status: Not Yet Recruiting → Unknown Status
Jan 2021 — Jan 2022 [monthly]

Not Yet Recruiting NA
Feb 2020 — Jan 2021 [monthly]

Not Yet Recruiting NA

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

France Parkinson Association
University Hospital, Toulouse

Data source: University Hospital, Toulouse

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Toulouse, France